Arca
Skip to content

Modification To Escort Ii+ 400 Series 9ESCORT Prism) Monitor, Models 20400, 20401, 20403, 20411, 20412, 20413, 20414

Oximeter. 510(k) K014294, from Medical Data Electronics (Arleta, CA). Product code DQA, class 2.

As of Nov 17, 2026, K014294 is an FDA 510(k) held by Medical Data Electronics, substantially equivalent on Jan 25, 2002 after 28 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jan 25, 2002
  • Review time: 28 days
  • Recalls: 0
  • Cited as a predicate by: 1 device

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Medical Data Electronics ESCORT II+ 400 Series Monitor is a portable patient monitor intended to be used for monitoring vital signs of critically ill adult, pediatric and neonatal patients in the hospital environment.

Cited as a Predicate

1 later 510(k) summary names this device as a predicate

Other DQA Clearances

The newest 510(k)s for the same product code; their median review was 207 days; see every DQA device

Record

Type
Special
Received
Dec 28, 2001
Review panel
Cardiovascular
Regulation
21 CFR 870.2700

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.